us > Maine > Oxford > Gilead > Latest & Local News
Gilead news
Gilead Sciences Completes Long-Term Study on Filgotinib for Rheumatoid Arthritis - TipRanks
Gilead Sciences Completes Long-Term Study on Filgotinib for Rheumatoid Arthritis TipRanks
Published on 3 July 2025 | 4:19 pm
August 22nd Options Now Available For Gilead Sciences (GILD) - Nasdaq
August 22nd Options Now Available For Gilead Sciences (GILD) Nasdaq
Published on 3 July 2025 | 2:55 pm
Gilead’s Voluntary License on Lenacapavir: Key Limitations of the License and Recommendations to Improve Access - MSF Access Campaign
Gilead’s Voluntary License on Lenacapavir: Key Limitations of the License and Recommendations to Improve Access MSF Access Campaign
Published on 3 July 2025 | 1:17 pm
Gilead Sciences (GILD) Announces that US FDA Approves Yeztugo®as pre-exposure prophylaxis (PrEP) - Insider Monkey
Gilead Sciences (GILD) Announces that US FDA Approves Yeztugo®as pre-exposure prophylaxis (PrEP) Insider Monkey
Published on 3 July 2025 | 7:00 am
Gilead Sciences’ Promising Phase II Study on Sacituzumab Govitecan for Solid Tumors - TipRanks
Gilead Sciences’ Promising Phase II Study on Sacituzumab Govitecan for Solid Tumors TipRanks
Published on 2 July 2025 | 4:19 pm
Gilead Sciences Advances Pediatric Hepatitis B Treatment with Ongoing Study - TipRanks
Gilead Sciences Advances Pediatric Hepatitis B Treatment with Ongoing Study TipRanks
Published on 2 July 2025 | 4:04 pm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD - PR Newswire
Published on 2 July 2025 | 2:00 pm
Gilead Eyes HIV Market Domination With Twice-Yearly Yeztugo as GSK Trails - BioSpace
Gilead Eyes HIV Market Domination With Twice-Yearly Yeztugo as GSK Trails BioSpace
Published on 2 July 2025 | 4:02 am
Gilead Sciences: A Mixed Bag of Opportunities and Risks - MSN
Gilead Sciences: A Mixed Bag of Opportunities and Risks MSN
Published on 1 July 2025 | 11:42 pm
Gilead Sciences: A Mixed Bag of Opportunities and Risks - The Globe and Mail
Gilead Sciences: A Mixed Bag of Opportunities and Risks The Globe and Mail
Published on 1 July 2025 | 11:40 pm
Gilead Sciences: A Mixed Bag of Opportunities and Risks - The Motley Fool
Gilead Sciences: A Mixed Bag of Opportunities and Risks The Motley Fool
Published on 1 July 2025 | 11:00 pm
Gilead Sciences CEO O’Day sells $1.1 million in stock - Investing.com
Gilead Sciences CEO O’Day sells $1.1 million in stock Investing.com
Published on 1 July 2025 | 10:15 pm
SCOTUS ruling paves smooth launch path for Gilead's long-acting PrEP med Yeztugo, analyst says - Fierce Pharma
SCOTUS ruling paves smooth launch path for Gilead's long-acting PrEP med Yeztugo, analyst says Fierce Pharma
Published on 1 July 2025 | 1:24 pm
Gilead’s Yeztugo HIV Shot Poised For Wider Reach After SCOTUS Ruling On Preventive Coverage: Wells Fargo - Stocktwits
Published on 30 June 2025 | 7:05 pm
New HIV Drug Protects for 6 Months - EBONY Magazine
New HIV Drug Protects for 6 Months EBONY Magazine
Published on 30 June 2025 | 1:15 pm
Gilead continues development plans in Foster City - San Mateo Daily Journal
Gilead continues development plans in Foster City San Mateo Daily Journal
Published on 30 June 2025 | 12:30 pm
Gilead extends gains after Supreme Court upheld an Obamacare provision - Investing.com
Gilead extends gains after Supreme Court upheld an Obamacare provision Investing.com
Published on 30 June 2025 | 11:27 am
Top managers back Gilead breakthrough - Citywire
Top managers back Gilead breakthrough Citywire
Published on 30 June 2025 | 8:26 am
Supreme Court decision win for Gilead, says Wells Fargo - TipRanks
Supreme Court decision win for Gilead, says Wells Fargo TipRanks
Published on 29 June 2025 | 5:31 pm
Gilead, Kymera Partner in $750M Deal to Develop Novel Molecular Glue Degraders for Cancer - Yahoo Finance
Gilead, Kymera Partner in $750M Deal to Develop Novel Molecular Glue Degraders for Cancer Yahoo Finance
Published on 28 June 2025 | 8:16 am
Gilead Sciences Inc. stock outperforms competitors on strong trading day - MSN
Gilead Sciences Inc. stock outperforms competitors on strong trading day MSN
Published on 28 June 2025 | 7:33 am
Gilead shares rise after US top court ruling on preventive coverage - Reuters
Gilead shares rise after US top court ruling on preventive coverage Reuters
Published on 27 June 2025 | 9:15 pm
Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch
Gilead Sciences Inc. stock outperforms competitors on strong trading day MarketWatch
Published on 27 June 2025 | 8:30 pm
A Supreme Court Vote Buoyed Gilead, Exact. Here's Why. - Investor's Business Daily
A Supreme Court Vote Buoyed Gilead, Exact. Here's Why. Investor's Business Daily
Published on 27 June 2025 | 8:25 pm
Gilead Stock Rises On US Supreme Court Ruling In Favor Of Health Insurers Covering Preventive Care - MSN
Gilead Stock Rises On US Supreme Court Ruling In Favor Of Health Insurers Covering Preventive Care MSN
Published on 27 June 2025 | 6:53 pm
Gilead Stock Rises On US Supreme Court Ruling In Favor Of Health Insurers Covering Preventive Care - Stocktwits
Gilead Stock Rises On US Supreme Court Ruling In Favor Of Health Insurers Covering Preventive Care Stocktwits
Published on 27 June 2025 | 6:31 pm
Gilead shares rise after US top court ruling on preventive coverage - MSN
Gilead shares rise after US top court ruling on preventive coverage MSN
Published on 27 June 2025 | 5:22 pm
Gilead shares rise after US top court ruling on preventive coverage By Reuters - Investing.com
Gilead shares rise after US top court ruling on preventive coverage By Reuters Investing.com
Published on 27 June 2025 | 5:03 pm
Exas stock, Gilead stock rise on Supreme Court ruling (GILD) - Seeking Alpha
Exas stock, Gilead stock rise on Supreme Court ruling (GILD) Seeking Alpha
Published on 27 June 2025 | 4:10 pm
Gilead Shares Rise After US Top Court Ruling on Preventive Coverage - U.S. News & World Report
Gilead Shares Rise After US Top Court Ruling on Preventive Coverage U.S. News & World Report
Published on 27 June 2025 | 2:59 pm
Gilead shares rise after US top court ruling on preventative coverage - TradingView
Gilead shares rise after US top court ruling on preventative coverage TradingView
Published on 27 June 2025 | 2:52 pm
Gilead partners to advance novel oral oncology drug - European Pharmaceutical Review
Gilead partners to advance novel oral oncology drug European Pharmaceutical Review
Published on 27 June 2025 | 2:21 pm
Positive Outlook for Gilead Sciences Driven by Favorable Legal Outcomes and Strong Product Launches - TipRanks
Positive Outlook for Gilead Sciences Driven by Favorable Legal Outcomes and Strong Product Launches TipRanks
Published on 27 June 2025 | 1:07 pm
3 of the year’s most notable FDA nods - PharmaVoice
3 of the year’s most notable FDA nods PharmaVoice
Published on 27 June 2025 | 12:16 pm
Gilead blames low RSV infection rates last season for scrapping 2 obeldesivir trials - Fierce Biotech
Gilead blames low RSV infection rates last season for scrapping 2 obeldesivir trials Fierce Biotech
Published on 27 June 2025 | 8:09 am
Uptake of Gilead's Yeztugo will be swift, analyst says after discussion with HIV doc - Fierce Pharma
Uptake of Gilead's Yeztugo will be swift, analyst says after discussion with HIV doc Fierce Pharma
Published on 25 June 2025 | 6:51 pm
Gilead Sciences and Kymera Therapeutics Enter Into Exclusive Option and License Agreement to Develop Novel Oral Molecular Glue CDK2 Degraders - Business Wire
Published on 25 June 2025 | 11:00 am
Gilead signs up to $750 million cancer drug deal with Kymera Therapeutics - Reuters
Gilead signs up to $750 million cancer drug deal with Kymera Therapeutics Reuters
Published on 25 June 2025 | 7:00 am
Kymera adds Gilead as research partner, while advancing new candidate with Sanofi - BioPharma Dive
Kymera adds Gilead as research partner, while advancing new candidate with Sanofi BioPharma Dive
Published on 25 June 2025 | 7:00 am
Kymera suffers Sanofi setback but secures $750M Gilead deal - Fierce Biotech
Kymera suffers Sanofi setback but secures $750M Gilead deal Fierce Biotech
Published on 25 June 2025 | 7:00 am
Looking Back to the Future: Gilead’s Long-Standing Commitment to Help End the HIV Epidemic - Gilead Sciences
Looking Back to the Future: Gilead’s Long-Standing Commitment to Help End the HIV Epidemic Gilead Sciences
Published on 20 June 2025 | 7:00 am
FDA Approves a Twice-Yearly Shot to Prevent HIV - Time Magazine
FDA Approves a Twice-Yearly Shot to Prevent HIV Time Magazine
Published on 20 June 2025 | 7:00 am
Gilead’s CEO on the approval of a powerful new drug to prevent HIV - STAT
Gilead’s CEO on the approval of a powerful new drug to prevent HIV STAT
Published on 19 June 2025 | 7:00 am
US FDA approves Gilead's twice-yearly injection for HIV prevention - Reuters
US FDA approves Gilead's twice-yearly injection for HIV prevention Reuters
Published on 18 June 2025 | 7:00 am
FDA approves twice-yearly shot of Gilead drug for HIV prevention - BioPharma Dive
FDA approves twice-yearly shot of Gilead drug for HIV prevention BioPharma Dive
Published on 18 June 2025 | 7:00 am
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option - CNBC
Published on 18 June 2025 | 7:00 am
Gilead Sciences facility video - fox8live.com
Gilead Sciences facility video fox8live.com
Published on 18 June 2025 | 7:00 am
Gilead’s HIV drug could end epidemic, but the company has a dark side - Fast Company
Gilead’s HIV drug could end epidemic, but the company has a dark side Fast Company
Published on 18 June 2025 | 7:00 am
Should You Buy Gilead Stock At $110? - Forbes
Should You Buy Gilead Stock At $110? Forbes
Published on 18 June 2025 | 7:00 am
UNAIDS urges Gilead to drop price of new HIV prevention shot - UNAIDS
UNAIDS urges Gilead to drop price of new HIV prevention shot UNAIDS
Published on 18 June 2025 | 7:00 am
HIV protection with just two shots a year: FDA approves Gilead drug - STAT
HIV protection with just two shots a year: FDA approves Gilead drug STAT
Published on 18 June 2025 | 7:00 am
The world's only twice-a-year shot to prevent HIV could stop transmission — if people can get it - AP News
The world's only twice-a-year shot to prevent HIV could stop transmission — if people can get it AP News
Published on 18 June 2025 | 7:00 am
FDA Approves Gilead’s Twice-Yearly Injectable Lenacapavir (Yeztugo) for HIV Prevention - Contagion Live
FDA Approves Gilead’s Twice-Yearly Injectable Lenacapavir (Yeztugo) for HIV Prevention Contagion Live
Published on 18 June 2025 | 7:00 am
Gilead lays off 36 people after axing Oceanside expansion plan - Fierce Biotech
Gilead lays off 36 people after axing Oceanside expansion plan Fierce Biotech
Published on 16 June 2025 | 7:00 am
Gilead pauses trials of HIV combination therapy - STAT
Gilead pauses trials of HIV combination therapy STAT
Published on 11 June 2025 | 7:00 am
Why Gilead Sciences Stock Tumbled on Tuesday - The Motley Fool
Why Gilead Sciences Stock Tumbled on Tuesday The Motley Fool
Published on 11 June 2025 | 7:00 am
Gilead hit with FDA clinical hold for batch of HIV trials - Pharmaceutical Technology
Gilead hit with FDA clinical hold for batch of HIV trials Pharmaceutical Technology
Published on 11 June 2025 | 7:00 am
FDA Places Clinical Hold on Gilead's HIV Studies, Stock Down - Yahoo Finance
FDA Places Clinical Hold on Gilead's HIV Studies, Stock Down Yahoo Finance
Published on 11 June 2025 | 7:00 am
Is It Worth Investing in Gilead (GILD) Based on Wall Street's Bullish Views? - Nasdaq
Is It Worth Investing in Gilead (GILD) Based on Wall Street's Bullish Views? Nasdaq
Published on 11 June 2025 | 7:00 am
FDA slaps holds on five of Gilead's HIV studies - FirstWord Pharma
FDA slaps holds on five of Gilead's HIV studies FirstWord Pharma
Published on 10 June 2025 | 7:00 am
US FDA pauses Gilead trials testing experimental HIV pill combination - Reuters
US FDA pauses Gilead trials testing experimental HIV pill combination Reuters
Published on 10 June 2025 | 7:00 am
FDA slaps clinical hold on multiple Gilead HIV combo therapy trials, shares fall - Fierce Biotech
FDA slaps clinical hold on multiple Gilead HIV combo therapy trials, shares fall Fierce Biotech
Published on 10 June 2025 | 7:00 am
Gilead’s HIV Combo on Hold, With No Impact on FDA’s Pending Lenacapavir Decision - BioSpace
Gilead’s HIV Combo on Hold, With No Impact on FDA’s Pending Lenacapavir Decision BioSpace
Published on 10 June 2025 | 7:00 am
'We are in a good spot': Gilead's new chief medical officer is committed to pipeline diversification - Fierce Biotech
'We are in a good spot': Gilead's new chief medical officer is committed to pipeline diversification Fierce Biotech
Published on 9 June 2025 | 7:00 am
Gilead Gears Up To Challenge J&J in $20B Multiple Myeloma CAR -T Market - BioSpace
Gilead Gears Up To Challenge J&J in $20B Multiple Myeloma CAR -T Market BioSpace
Published on 4 June 2025 | 7:00 am
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO - CNBC
Published on 3 June 2025 | 7:00 am
Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial - Reuters
Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial Reuters
Published on 2 June 2025 | 7:00 am
Gilead's CAR-T cell therapy shows promise in deadly brain cancer - Reuters
Gilead's CAR-T cell therapy shows promise in deadly brain cancer Reuters
Published on 1 June 2025 | 7:00 am
Gilead commits to HIV prevention rollout for low-income countries despite funding uncertainty - Reuters
Gilead commits to HIV prevention rollout for low-income countries despite funding uncertainty Reuters
Published on 30 May 2025 | 7:00 am
Gilead pays partner Hookipa $10M to take over HBV, HIV therapeutic vaccine programs - Fierce Biotech
Gilead pays partner Hookipa $10M to take over HBV, HIV therapeutic vaccine programs Fierce Biotech
Published on 22 May 2025 | 7:00 am
Gilead Sciences vs GSK: Which HIV Drugmaker is a Smarter Buy Now? - Yahoo Finance
Gilead Sciences vs GSK: Which HIV Drugmaker is a Smarter Buy Now? Yahoo Finance
Published on 20 May 2025 | 7:00 am
Gilead, bracing for tariffs, joins peers in US drug production push - BioPharma Dive
Gilead, bracing for tariffs, joins peers in US drug production push BioPharma Dive
Published on 8 May 2025 | 7:00 am
Gilead tees up $11B in new US manufacturing, R&D investments - Fierce Pharma
Gilead tees up $11B in new US manufacturing, R&D investments Fierce Pharma
Published on 8 May 2025 | 7:00 am
Gilead Pumps $11B More Into US Manufacturing, Hopes To Add 3,000 Jobs - BioSpace
Gilead Pumps $11B More Into US Manufacturing, Hopes To Add 3,000 Jobs BioSpace
Published on 8 May 2025 | 7:00 am
Bringing PBC Into Focus Through Art of Patient Stories - Gilead Sciences
Bringing PBC Into Focus Through Art of Patient Stories Gilead Sciences
Published on 7 May 2025 | 7:00 am
Gilead boosts planned US investments by $11 billion amid tariff threat - Reuters
Gilead boosts planned US investments by $11 billion amid tariff threat Reuters
Published on 7 May 2025 | 7:00 am
Speaker Program Settlement Highlights Compliance Risks for Life Sciences Companies - Skadden, Arps, Slate, Meagher & Flom LLP
Speaker Program Settlement Highlights Compliance Risks for Life Sciences Companies Skadden, Arps, Slate, Meagher & Flom LLP
Published on 6 May 2025 | 7:00 am
Gilead Sciences to pay $202 million in US settlement over HIV drug kickbacks - Reuters
Gilead Sciences to pay $202 million in US settlement over HIV drug kickbacks Reuters
Published on 29 April 2025 | 7:00 am
Gilead to pay $202 million to settle doctor kickback claims related to HIV drug prescriptions - CNBC
Gilead to pay $202 million to settle doctor kickback claims related to HIV drug prescriptions CNBC
Published on 29 April 2025 | 7:00 am
Gilead, 'closely attuned to' potential US policy shifts, stands by long-acting PrEP launch - Fierce Pharma
Gilead, 'closely attuned to' potential US policy shifts, stands by long-acting PrEP launch Fierce Pharma
Published on 25 April 2025 | 7:00 am
Gilead leans on HIV drugs as oncology sales slow - BioPharma Dive
Gilead leans on HIV drugs as oncology sales slow BioPharma Dive
Published on 25 April 2025 | 7:00 am
Gilead posts profit, says HIV prevention drug on track for mid-June - Reuters
Gilead posts profit, says HIV prevention drug on track for mid-June Reuters
Published on 24 April 2025 | 7:00 am
Gilead Sciences Announces First Quarter 2025 Financial Results - Business Wire
Gilead Sciences Announces First Quarter 2025 Financial Results Business Wire
Published on 24 April 2025 | 7:00 am
Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer type - Reuters
Gilead says Trodelvy-Keytruda combo effective for aggressive breast cancer type Reuters
Published on 21 April 2025 | 7:00 am
AIDSVu Online Mapping Tool Helps Visualize HIV’s Impact in the United States - Gilead Sciences
AIDSVu Online Mapping Tool Helps Visualize HIV’s Impact in the United States Gilead Sciences
Published on 9 April 2025 | 7:00 am
Gilead encouraged by data on once-yearly lenacapavir for HIV prevention - Healio
Gilead encouraged by data on once-yearly lenacapavir for HIV prevention Healio
Published on 14 March 2025 | 7:00 am
Gilead data suggest once-yearly shot of PrEP drug blocks HIV infection - STAT
Gilead data suggest once-yearly shot of PrEP drug blocks HIV infection STAT
Published on 11 March 2025 | 7:00 am
Advancing Oncology Care Through Gilead's Research Scholars Program - Gilead Sciences
Advancing Oncology Care Through Gilead's Research Scholars Program Gilead Sciences
Published on 5 March 2025 | 8:00 am
IDEAYA Announces Further Gilead Sciences Clinical Study Collaboration Evaluating Combination of Trodelvy® and IDE397 in MTAP-Deletion NSCLC - PR Newswire
Published on 13 February 2025 | 8:00 am
Access Strategy for Long-Acting PrEP - Gilead Sciences
Access Strategy for Long-Acting PrEP Gilead Sciences
Published on 10 February 2025 | 3:03 pm
Discovering a Breakthrough: Gilead’s Long-Standing Commitment to Helping Change the Course of HIV - Gilead Sciences
Discovering a Breakthrough: Gilead’s Long-Standing Commitment to Helping Change the Course of HIV Gilead Sciences
Published on 5 February 2025 | 8:00 am
Dietmar Berger, MD, PhD - Gilead Sciences
Dietmar Berger, MD, PhD Gilead Sciences
Published on 2 January 2025 | 3:52 am
2024 Gilead Oncology Grant Recipients - Gilead Sciences
2024 Gilead Oncology Grant Recipients Gilead Sciences
Published on 26 November 2024 | 5:54 am
Giving in North America - Gilead Sciences
Giving in North America Gilead Sciences
Published on 18 September 2024 | 7:39 am
Targeting COVID-19 and Emerging Viruses - Gilead Sciences
Targeting COVID-19 and Emerging Viruses Gilead Sciences
Published on 18 September 2024 | 7:39 am
Diversity in Clinical Trials: Gilead’s Commitment to Inclusive Clinical Research - Gilead Sciences
Diversity in Clinical Trials: Gilead’s Commitment to Inclusive Clinical Research Gilead Sciences
Published on 18 September 2024 | 7:25 am
Gilead Sciences Oncology: New Hope for People with Cancer - Gilead Sciences
Gilead Sciences Oncology: New Hope for People with Cancer Gilead Sciences
Published on 18 September 2024 | 6:48 am
Gilead Foundation: Building Health Equity in Communities - Gilead Sciences
Gilead Foundation: Building Health Equity in Communities Gilead Sciences
Published on 18 September 2024 | 6:44 am
Career Opportunities - Gilead Sciences
Career Opportunities Gilead Sciences
Published on 18 September 2024 | 5:47 am